Bausch Health
BHC
#3383
Rank
โ‚น289.85 B
Marketcap
โ‚น788.06
Share price
-0.85%
Change (1 day)
38.28%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

Bausch Health (BHC) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚น1.814 Trillion

According to Bausch Health 's latest financial reports the company's total debt is โ‚น1.814 Trillion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bausch Health - Total debt on balance sheet (from 1996 to 2023)

Total debt by year

Year Total debt Change
2023-12-31โ‚น1.863 T8.46%
2022-12-31โ‚น1.718 T1.91%
2021-12-31โ‚น1.686 T-3.63%
2020-12-31โ‚น1.749 T-5.25%
2019-12-31โ‚น1.846 T8.66%
2018-12-31โ‚น1.699 T4.61%
2017-12-31โ‚น1.624 T-19.9%
2016-12-31โ‚น2.028 T-1.88%
2015-12-31โ‚น2.067 T114.07%
2014-12-31โ‚น965.57 B-10.07%
2013-12-31โ‚น1.073 T77.85%
2012-12-31โ‚น603.71 B71.59%
2011-12-31โ‚น351.83 B112.71%
2010-12-31โ‚น165.41 B808.75%
2009-12-31โ‚น18.20 B494.5%
2008-12-31โ‚น3.06 B
2006-12-31โ‚น18.18 B-7.51%
2005-12-31โ‚น19.65 B-5.22%
2004-12-31โ‚น20.74 B-43.93%
2003-12-31โ‚น36.99 B3.22%
2002-12-31โ‚น35.83 B1509.04%
2001-12-31โ‚น2.22 B-93.54%
2000-12-31โ‚น34.47 B476.77%
1999-12-31โ‚น5.97 B10.78%
1998-12-31โ‚น5.39 B2701.99%
1997-12-31โ‚น0.19 B-23.48%
1996-12-31โ‚น0.25 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น22.73 B-98.75%๐Ÿ‡บ๐Ÿ‡ธ USA